AI Resilience Report forPhysicians, Pathologists

If you're thinking about becoming a pathologist, here's some good news: AI is becoming a helpful teammate in this field, not a replacement. Pathologists are the doctors who study tissue and body fluids to diagnose diseases like cancer, and today AI is mainly being used to augment their work — assisting with tasks like measuring biomarkers, spotting patterns on slides, and flagging quality problems. According to a recent article in Medical Laboratory Observer, the most impactful role of AI in pathology is not replacement but augmentation, with AI supporting tasks such as quantification, pattern recognition, and workflow optimization while the pathologist remains central to interpretation, clinical context, and patient decision-making.

Regulators are steadily clearing new tools — for example, Imaging Technology News reported the FDA clearance of ArteraAI Breast ^[1], an AI test for early-stage breast cancer, and News-Medical covered Leica Biosystems' industry-first AI‑assisted quality control clearance ^[2] for digital pathology. Uniquely human tasks — autopsies, teaching residents, supervising labs, and making the final call on tricky cases — remain firmly in pathologists' hands.

Adoption is real but slower than the headlines suggest. In a College of American Pathologists podcast summarizing the 2025 Pathologist Leadership Survey ^[3], just 26% of 378 practice leaders said they are digitizing glass slides using whole slide imaging, and only 15% of pathology practices overall use WSI for primary diagnosis — a necessary first step before AI can even be applied. KLAS Research similarly notes ^[4] that fewer than 15% of US healthcare organizations are at some stage of deployment with a digital pathology solution, and even among early adopters, full digital conversion is uncommon.

Two big forces are pushing adoption faster, though: workforce shortages and rising case complexity. Labcorp warns of a "staffing cliff," ^[5] explaining that a large cohort of pathologists is reaching retirement age, creating a measurable gap between diagnostic demand and available staffing, alongside declining residency fill rates and geographic barriers to subspecialty expertise. The American Society for Clinical Pathology's 2024 Vacancy Survey summary ^[6] confirms this pressure, reporting that 10 out of 17 laboratory departments reported increased retirements, and adapting to AI emerged as the most common operational challenge, though respondents expressed optimism about AI's potential to transform laboratory workflows.

Slower brakes include high scanner and software costs, strict FDA rules, patient-safety concerns, and the need for careful validation. The takeaway for students: pathology is being reshaped by AI, but human judgment, teaching, and leadership are more valuable than ever.